Medical Devices
Medical Device NCL-SPEC1 - SPEC1-CE
The medical device NCL-SPEC1 is realized by LEICA BIOSYSTEM NEWCASTLE LTD
| Trade name | NCL-SPEC1 |
| Product Code | SPEC1-CE |
| Manufacturer of the medical device | LEICA BIOSYSTEM NEWCASTLE LTD |
| Tax code of the producer | 0 |
| Vat Number | 974971070 |
| Category Name | PRIMARY ANTISERA FOR IMMUNOHISTOLOGY |
| Category Code | W01030709 |
| Sign repertoire | Registered |
| Group of similar Medical devices | 0 |
| Medical device reference | 0 |
| Type | Medical Device Class |
| Progressive number assigned to the medical device | 1788887 |
| Effective Date | Saturday 16 February 2019 |
| End date | End of validity is not present for the medical device |
| End date trade | Medical device still on the market |
| Date of first publication | Saturday 16 February 2019 |
Della stessa categoria di dispositivi medici:
- PAX-8 0.1 ML CONCENTRATED RMAB EP298 IGG - BSB 3144
- BAP1 0.5 ML CONCENTRATED MMAB BSB-109 IGG1 / K - BSB 3304
- SALL4 0.1 ML CONCENTRATED MMAB 6E3 IGG1 / K - BSB 3186
- ARGINASE-1 0.1 ML CONCENTRATED RMAB EP261 IGG - BSB 2450
- TLE1 0.5 ML CONCENTRATED MMAB 1F5 IGG1 / K - BSB 2318
- SOX10 0.5 ML CONCENTRATED RMAB EP268 IGG - BSB 2584
- CARBONIC ANHYDRASE 9 0.1 ML CONCENTRATED RMAB EP161 IGG - BSB 6418